What Is MOTS-c?
Mitochondria are best known as the energy producers inside your cells. In 2015, researchers discovered that mitochondria also make small signaling peptides of their own. MOTS-c is one of them, a 16-amino-acid peptide that appears to communicate with the rest of the cell about energy and fuel use. The form prescribed at Evolve Health is MOTS-c acetate.
What Researchers Are Studying
In people, MOTS-c levels in muscle and blood rise sharply during exercise and tend to be lower with age. Animal research has looked at its role in how the body handles glucose and fat. A placebo-controlled human trial is now studying whether MOTS-c changes insulin sensitivity in adults with early metabolic changes. Areas of interest include:
- Insulin sensitivity and metabolic health
- Energy and exercise capacity
- Healthy aging
How It's Prescribed at Evolve Health
MOTS-c acetate is prescribed as a subcutaneous or intramuscular injection. It is always a single ingredient and is never combined with another peptide. Prescriptions are written for one patient and filled by a LegitScript-certified 503A compounding pharmacy using ingredients from FDA-registered facilities with a certificate of analysis.
MOTS-c is not a substitute for nutrition, movement, or medical weight-loss care. When metabolic health is the goal, your provider looks at the whole picture first.
Is MOTS-c Right for You?
A comprehensive consultation, health history, medications, labs such as fasting glucose and insulin, and your goals, tells your provider whether MOTS-c makes sense for you or whether another path is a better starting point.
Disclaimer: Compounded peptides are not FDA-approved for the diagnosis, treatment, cure, or prevention of any disease. The FDA does not evaluate or verify the safety, effectiveness, or quality of compounded drugs. These peptides may be prescribed in certain cases based on individual clinical judgment following a patient-specific evaluation, and prescriptions are fulfilled exclusively by a LegitScript-certified 503A compounding pharmacy pursuant to a patient-specific prescription. Results vary. Information current as of November 2026.
